A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Local Institution - 0027, Wollongong

Local Institution - 0037, Melbourne

Local Institution - 0005, Heidelberg

Local Institution - 0006, Clayton

Local Institution - 0025, Bergen

Local Institution - 0040, Marseille

Local Institution - 0017, Rozzano

Local Institution - 0026, Milan

Local Institution - 0015, Lund

Local Institution - 0036, Madrid

Local Institution - 0023, Toulouse

Local Institution - 0047, Miami

Local Institution - 0020, Pessac

Local Institution - 0035, Salamanca

Local Institution - 0028, Santander

Local Institution - 0029, Nantes

Local Institution - 0018, Meldola

Local Institution - 0001, Houston

Local Institution - 0030, Los Angeles

Local Institution - 0031, Palo Alto

Local Institution - 0041, Villejuif

Local Institution - 0019, Edmonton

Local Institution - 0011, Vancouver

Local Institution - 0010, Toronto

Local Institution - 0038, Montreal

Local Institution - 0013, Oslo

Local Institution - 0032, Badalona

Local Institution - 0039, Barcelona

Local Institution - 0021, Gothenburg

Local Institution - 0014, Stockholm

Local Institution - 0044, Edinburgh

Local Institution - 0050, Oxford